Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes.
Anton Y
AY
Peleg
Jan M
JM
Bell
Ann
A
Hofmeyr
Peter
P
Wiese
D000151:Acinetobacter Infections / Q000453:epidemiology* / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects / Q000201:enzymology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002405:Catheterization, Central Venous / Q000009:adverse effects; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology*; D014546:Urinary Catheterization / Q000009:adverse effects; D001618:beta-Lactamases / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001618:beta-Lactamases; C509061:beta-lactamase OXA-58, Acinetobacter junii; C477893:beta-lactamase bla(VIM-4), Pseudomonas aeruginosa